Farms.com Home   News

World class grain system must be maintained

Recently there has been a public push by the Western Canadian Wheat Growers to change the Canadian varietal registration and grading system to allow American grown wheat full access into our export system. As usual, their simplistic approach ignores the economic pitfalls that Canadian farmers will face should this occur.

Canada’s grading system is unique in the world, with all of the wheat varieties that are accepted into our system assigned to a specific class that is based upon their characteristics. These characteristics include such things as protein content, and ensure uniformity within the class so that our customers are assured of a product that meets their end needs.

The Americans, however, simply accept any variety that is put forward, and it is up to customers to test each and every shipment to determine if it meets their specifications. As well, it is up to every farmer to decide if a variety meets both their own agronomic needs, and the end-use needs of potential customers.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.